Therapeutics for cognitive aging

Redefining Aging in HIV Infection Using Phenotypes

Purpose of review

This article critically reviews the utility of “phenotypes” as behavioral descriptors in aging/HIV research that inform biological underpinnings and treatment development. We adopt a phenotypic redefinition of aging conceptualized within a broader context of HIV infection and of aging. Phenotypes are defined as dimensions of behavior, closely related to fundamental mechanisms, and, thus, may be more informative than chronological age. Primary emphasis in this review is given to comorbid aging and cognitive aging, though other phenotypes (i.e., disability, frailty, accelerated aging, successful aging) are also discussed in relation to comorbid aging and cognitive aging.

Recent findings

The main findings that emerged from this review are as follows: (1) the phenotypes, comorbid aging and cognitive aging, are distinct from each other, yet overlapping; (2) associative relationships are the rule in HIV for comorbid and cognitive aging phenotypes; and (3) HIV behavioral interventions for both comorbid aging and cognitive aging have been limited.

Summary

Three paths for research progress are identified for phenotype-defined aging/HIV research (i.e., clinical and behavioral specification, biological mechanisms, intervention targets), and some important research questions are suggested within each of these research paths.

A randomized, double-blind, placebo controlled, parallel group, efficacy study of alpha BRAIN® administered orally

OBJECTIVE

Alpha BRAIN® is a nootropic supplement that purports to enhance cognitive functioning in healthy adults. The goal of this study was to investigate the efficacy of this self-described cognitive enhancing nootropic on cognitive functioning in a group of healthy adults by utilizing a randomized, double blind, placebo-controlled design.

METHODS

A total of 63-treatment naïve individuals between 18 and 35 years of age completed the randomized, double-blind, placebo controlled trial. All participants completed a 2-week placebo run in before receiving active product, Alpha BRAIN® or new placebo, for 6 weeks. Participants undertook a battery of neuropsychological tests at randomization and at study completion. Primary outcome measures included a battery of neuropsychological tests and measures of sleep.

RESULTS

Compared with placebo, Alpha BRAIN® significantly improved on tasks of delayed verbal recall and executive functioning. Results also indicated significant time-by-group interaction in delayed verbal recall for the Alpha BRAIN® group.

CONCLUSIONS

The use of Alpha BRAIN® for 6 weeks significantly improved recent verbal memory when compared with controls, in a group of healthy adults. While the outcome of the study is encouraging, this is the first randomized controlled trial of Alpha BRAIN®, and the results merit further study.

Nutraceutical intervention improves older adults' cognitive functioning

Interventions to improve the cognitive health of older adults are of critical importance. In the current study, we conducted a double-blind, placebo-controlled clinical trial using a pill-based nutraceutical (NT-020) that contained a proprietary formulation of blueberry, carnosine, green tea, vitamin D3, and Biovin to evaluate the impact on changes in multiple domains of cognitive functioning. One hundred and five cognitively intact adults aged 65-85 years of age (M=73.6 years) were randomized to receive NT-020 (n=52) or a placebo (n=53). Participants were tested with a battery of cognitive performance tests that were classified into six broad domains--episodic memory, processing speed, verbal ability, working memory, executive functioning, and complex speed at baseline and 2 months later. The results indicated that persons taking NT-020 improved significantly on two measures of processing speed across the 2-month test period in contrast to persons on the placebo whose performance did not change. None of the other cognitive ability measures were related to intervention group. The results also indicated that the NT-020 was well tolerated by older adults, and the presence of adverse events or symptoms did not differ between the NT-020 and placebo groups. Overall, the results of the current study were promising and suggest the potential for interventions like these to improve the cognitive health of older adults.

Brain axial and radial diffusivity changes with age and gender in healthy adults

White matter integrity changes with age, with the extent of variation dependent on attributes such as sex and oligodendrocyte health. Quantification of myelin and axonal integrity in healthy people would provide normative values necessary to determine pathology-related tissue characteristics with normal-aging and gender. We assessed white matter integrity with diffusion tensor imaging-based axial and radial diffusivity procedures (3.0-Tesla magnetic resonance imaging), which measure water diffusion parallel and perpendicular to axonal bundles, indicating axonal and myelin status, respectively, using region-of-interest (ROI) analyses, in 34 healthy adults (age, 46.5 ± 6.0 years, 19 male). Sex differences in diffusion values were assessed with two-sample t-tests, and diffusion changes with age using Pearson's correlations; whole-brain effect sizes were examined with voxel-based procedures. Multiple brain areas showed increased axial and radial diffusivity values reflecting declines in axonal and myelin integrity with age, especially in mid-hippocampal and posterior thalamic areas. However, axonal and myelin integrity increased in insular and occipital cortex projections with maturity. Females showed reduced fiber and myelin integrity in substantially more structures than males, and those areas included limbic, basal ganglia, pontine, and cerebellar sites. A minority of structures, confined to cerebellar, temporal, and frontal cortices, showed reduced fiber and myelin integrity with age in males over females. Whole-brain effect sizes in diffusion values between sexes and age-related changes showed findings parallel to ROI analyses. The structural differences mandate partitioning of sex and age in adult white matter pathology assessment, and likely contribute to sex-based physiological and behavioral dysfunction in aging and in multiple pathologies.

Morphological and biochemical studies on aging and autophagy

To maintain health in the elderly is a crucial objective for modern medicine that involves both basic and clinical researches. Autophagy is a fundamental auto-cannibalizing process that preserves cellular homeostasis and, if altered, either by excess or defect, greatly changes cell fate and can result in incapacitating human diseases. Efficient autophagy may prolong lifespan, but unfortunately this process becomes less efficient with age. The present review is focused on the close relationship between autophagy and age-related disorders in different tissues/organs and in transgenic animal models. In particular, it comments on the up to date literature on mechanisms responsible for age-related impairment of autophagy. Moreover, before discussing about these mechanisms, it is necessary to describe the metabolic autophagic regulation of autophagy and the proteins involved in this process. At the end, these data would summarize the autophagic link with aging process, as important tools in the future biogerontology scenario.

Intelligence

Individual differences in human intelligence are of interest to a wide range of psychologists and to many people outside the discipline. This overview of contributions to intelligence research covers the first decade of the twenty-first century. There is a survey of some of the major books that appeared since 2000, at different levels of expertise and from different points of view. Contributions to the phenotype of intelligence differences are discussed, as well as some contributions to causes and consequences of intelligence differences. The major causal issues covered concern the environment and genetics, and how intelligence differences are being mapped to brain differences. The major outcomes discussed are health, education, and socioeconomic status. Aging and intelligence are discussed, as are sex differences in intelligence and whether twins and singletons differ in intelligence. More generally, the degree to which intelligence has become a part of broader research in neuroscience, health, and social science is discussed.